Sponsor or institution

Clinical trials and research at Azafaros B.V.

• 2Clinical trials
• 17Countries

All recruiting trials (2)

• Oral nizubaglustat (AZ-3102) for late‑infantile and juvenile Niemann‑Pick Type C

  This 18-month randomized, placebo-controlled study tests whether daily oral nizubaglustat reduces ataxia and improves other symptoms in children and adolescents with late‑infantile or juvenile Niemann‑Pick Type C disease.

  Recruiting at 27 sites Phase 3 Azafaros B.V. · Oakland, California and 33 other locations · NCT07082725

• Oral nizubaglustat (AZ-3102) for late‑infantile and juvenile Niemann‑Pick C, GM1, and GM2 gangliosidoses

  This 18‑month study will test whether daily oral nizubaglustat (AZ‑3102) helps people age 4 and up with late‑infantile or juvenile Niemann‑Pick C, GM1, or GM2 gangliosidosis compared with placebo.

  Recruiting at 29 sites Phase 3 Azafaros B.V. · Oakland, California and 38 other locations · NCT07054515

Quick answers

How many clinical trials run by Azafaros B.V. are recruiting right now?

2, as of November 12, 2026. We update this list each time we refresh our data from ClinicalTrials.gov.

Where are these trials running?

In 17 countries. The most sites are in Argentina (2 trials), Australia (2 trials), Brazil (2 trials), Canada (2 trials), Germany (2 trials). Each study page lists its sites and which ones are recruiting.

What phases are they in?

Phase 3: 2. Trials with no phase listed are usually device, behavioural or observational studies.

How do I join one?

Open a study, check the "Is this trial a fit for you?" section, then contact the study team listed on the page. They will ask a few screening questions. Asking is free and does not commit you to anything. Talk it over with your doctor first.

Find the studies that fit you

A list is a starting point. Tell us your situation in your own words and we'll rank the studies that match and explain why. It's free and needs no account.

Describe your situation →